Local antisera (LA) were compared with a common interim reference antiserum (IRA) to examine the antiserum component of the among-laboratory vanation in an international collaborative study with 28 laboratories evaluating a candidate international Reference Matenal (apo-RM) for apolipoproteins A-I (apo A-I) and B (apo B). Measurement of the relative concentration of lyophilized preparations differed by <1% for LA and IRA. The percentage of the total variation in measurement of the concentration of apo-RM that was contributed by antisera among laboratories was 5% and 8% for apo A-I and B, respectively. Estimated differences from overall mean concentrations for the five different immunomethods were greater for apo B (range: +22% to -23.5%) than for apo A-I (range + 14.1% to -14%), but were similar within a method for LA and IRA. The results indicated that antisera are not a major source of error among laboratories and, indeed, are responsible for relatively little of the total variability. demonstrated a large total coefficient of variation (CV) for the reported measurements (1). The largest source of error was attributed to among-laboratory differences. An international collaborative study was next designed and performed with 28 selected laboratories in 1984-1985 to validate the candidate apo-RM vs "fresh" sera in dose-response curves, to study the sources of error associated with the different types of immuno-methods, and to compare results on using local antisera (LA) reagents and a rabbit polyclonal interim reference antisera (IRA) provided to the participant laboratories. The validation of the apo-RM and the examination of its performance in different immuno-methods are presented in Part I of this study (2).
sary to develop a reference antisera along with the reference calibration material as an integral component of the complete reference system (3). Reported results for an evaluation of immunoassays for kinin concentrations in blood depend at least in part on the antiserum to bradykinin that is used in the assay. Results were affected by crossreactivity and an unknown interfering component of blood, and these differently influenced the four antisera tested (4) .
Antisera evaluation was integrated into the design of the present apolipoprotein study to examine its potential contribution to the total error component, to determine if a reference antiserum would be required to validate an apo-RM, and to standardize laboratory measurements of ape A-I and B.
The overall results of this collaborative study, which involved 28 laboratories, suggest that anti-apolipoprotein sera diversity is not a major component of error but instead is responsible for only an almost-negligible proportion of the total variability encountered among laboratories in the quantification of ape A-I and B. Detailed results are reported on the contribution of antisera as a source of error. The impact of antisera difference is examined for slope bias, determination of relative concentration, and method dependence among the collaborating laboratories.
Materials and Methods3

Preparation of Apolipoprotein A-I and B Antigens
Apo A-I used as an immunogen was isolated (5) from high-density lipoprotein prepared by the method of Havel et al. (6) . Homogeneity was established by electrophoresis on polyacrylainide gel in buffers containing urea and sodium dodecyl sulfate (7, 8) and by quantitative analysis for amino acids (9, 10). Low-density lipoprotein, used as the apo B antigen, was obtained from at least three serum pools collected from fasting donors. The LDL was prepared by sequential isopyenic ultracentrifugation. After isolation of lipoproteins of d >1.006 to 1.063 kg/L, the LDL was reisolated at d = 1.019 to 1.063 kgfL and subsequently recentrifuged at the higher density.
Preparation of Antisera
New Zealand White rabbits were injected at multiple subcutaneous sites with either purified apo A-I or LDL during several months. Antigen for injection, usually 1 mg dissolved in 0.5 mL of phosphate-buffered isotonic saline (pH 7.0) and 0. view, NY) to yield a stable emulsion. Antisera harvested from multiple bleedings were collected over a nine-month period, tested for titer and crossreactivity, then pooled and stored at -20 "C.
Characterization of Interim Reference Antisera
Antisera to ape A-I were tested for cross reactivity by immunodiffusion (11) against apolipoproteins B, E, A-il, C-I, C-il, and C-rn. Minor crossreactivity against ape B and ape D was noted on use of "high sensitivity" crossed immunoelectrophoresis. Because the cross reactivity was negligible at the low (60-fold) dilution and probably nonexistent at the working dilution range of most inimuno-methods, the antisera were deemed useflil, capable of providing quantitative results. Pooled ape A-I antisera gave similar slopes and displacement curves against purified ape A-I, isolated highdensity lipeproteins (d = 1.063 to 1.21 g/mL), and dilutions of freshly obtained human sera in our radioimmunoassay technique (12). Western-blot analysis of ape A-I isoforms (13, 14) separated by two-dimensional gel electrophoresis (15) containing ampholyte (1%, pH 4-6; Ampholine, LKB Products AB, Bromnia, Sweden), with immunoperoxidase detection, demonstrated that the rabbit anti-ape A-I sera bound to all isoforms in a way qualitatively similar to gels stained with silver or Coomassie Brilliant Blue R-250 (16).
Pooled rabbit antisera to ape B produced well-defined immunoreactivity in the crossed immunoelectrophoresis evaluation, and there was no cross reactivity with other apolipoproteins (A-I, A-il, C-I, C-il, C-ffl, D, or E). The RIA (17) in which the pooled anti-ape B sera were used gave similar slope estimates for fresh human sera and isolated LDL. Detection with immunoperoxidase after transblotting of 30 g/L sodium dodecyl sulfate/pelyacrylamide gels (18) indicated that the antisera did not bind to apolipoprotein B-48 in chylomicrons and very-low-density lipoproteins obtained from a normal subject after he had ingested a fatty meal but did bind B-100 in VLDL from plasma obtained from the fasting subject. Although the IRA was raised to an ultracentrifugally isolated density fraction of low-density lipoprotein, it has reactivity only with apolipoprotein B-100. Both antisera, anti-ape A-I and anti-ape B, are termed "interim reference antisera" (IRA). Both IRA, tested in the ELISA with antigen-coated wells of microtiter plates, were found to perform with quantitative efficiency.
Study Protocol
The statistical methods and the protocol are detailed in Part I of this study (2) . Five different dilutions of the lyophilized apo-RM, lyophilized apo-QCM, and the four fresh human sera were measured by the participant laboratories, using both the IRA and LA, in separate runs, on at least three different days. All the dilutions were such that the results fell within the dose-response curve. Each participant laboratory had to determine the working titer for the IRA for ape A-I and B relative to its particular immunomethod.
Results
The overall mean values for percentage differences in the relative concentration of the apo-RM and the apo-QCM with LA and IRA were <1% for both ape A-I and B (ape A-I, -0.50%, n = 15; ape B, 0.93%, n = 17). The individual percentage differences for mean values between the two materials with the two antisera are plotted, by laboratory and method, in Figure 1 . Values of less than ±10% were obtained for both apolipoproteins by most laboratories, and the values tended to cluster around zero, with no consistent trends in the relative concentration with the four different iminuno-methods.
The data for the EIA is not included for Figure 1 because of difficulties of participants in following the study protocol to yield a linear dose-response curve (see ref.
2). Three of the four laboratories with greater than ± 10% differences for mean values between the materials used RID methods.
In Table 1 we give the combined apo-RM and apo-QCM mean for the percent absolute slope bias and the signed (negative or positive) slope bias for dose-response curves, all by antiserum type. The absolute percent bias disregards the signs of the bias for the lyophilized materials. absolute percent bias for apo-QCM and apo-RM determined per run and averaged across all laboratories.
The bias is
The percent bias of the mean value of apo-QCM and apo-RM slopes was determined vs the mean value for slopes for the four fresh sera for each run. These were averaged across three runs for each laboratory. The percent bias for the apo-RM and apo-QCM materials did not disregard the signs. If the slope for the reference sera is equal to that for the fresh sera, the percent bias is zero. The mean value for absolute bias is approximately 13% for ape B with both IRA and LA. For ape A-I, the absolute bias is somewhat greater for LA than for IRA. None of the mean values for the signed bias results differ significantly from zero. The calculated slopes for the apo-RM for the three analytical runs by each participant indicate, with the IRA and LA, that almost all laboratories obtained very similar slopes on using the two antisera types with fresh sera and lyophilized preparations. Only one laboratory showed a distinct difference, and that only for ape B. Table 2 gives the respective role of antisera as a source of variation in the percent slope bias of the apo-RM from that of the fresh sera. The analysis is shown for both the signed and unsigned bias. If one disregards the sign, antisera differences account for only 11% of the total variance in slopebias for ape A-I, and only 2% when the sign of the slope is considered. For ape B the antisera appear to play a greater role in the bias of the slopes, accounting for 28% and 39% of the total variation when the sign is disregarded or considered, respectively.
In Figure 2 the within-laboratory CVs with LA and IRA, respectively, are shown as the point at the end of each line by participant for the apo-RM. The within-laboratory CV ranges from 32% to <5% for ape A-I and from 27% to <5% for ape B, with CVs for most laboratories falling below 10% for both apolipoproteins. No pattern in the CV and antiserum type (LA or IRA) was observed. Overall, the CVs appear higher for ape B than ape A-I, and the results indicate no consistent relationship between CV and apolipeprotein concentration for the laboratories. Table 3 Table 4 shows the respective differences (in percent) from the overall mean concentration for the apo-RM by method and antiserum type. These differences were derived by using one mean concentration value per laboratory, and all methods are included. The magnitudes of the differences regardless of antisera type are clearly larger for ape B. The differencesforthe RIA method are small for both proteins. However, RID and ELISA show high negative bias, whereas the INA and EIA methods show high positive bias. The overall mean values for the estimates of relative concentration for ape A-I and B for the apo-RM by method and antisera type are given in Table 5 . The mean values for ape A-I with the IRA and the LA differ by only about 2%, whereas the respective mean values for ape B differ by about (Figure 3) in the results for ape B. The values reported by  laboratories B, 1, and 2 are markedly lower for LA and are slightly lower in laboratories K and U. Studies on the concentration of the apo-QCM relativeto that of the apo-RM, comparison of dose-response slopes of the apo-RM vs fresh serum, and determination of the concentration of the apo-RM all produced results that showed substantial agreement between results from immunoassays in which the IRA and the LA were used, whether monoclonal or polyclonal antisera were used. Results reported by 15 international laboratories measuring ape A-I and 18 measuring ape B indicate that only a small part of the total variability in analytical performance may be attributed to differences in antisera. Mean percent differences were less than 1% in the concentration of the apo-QCM relativeto that of the apo-RM, for both the IRA and the LA. The mean values for percent slope bias of the apo-RM vs fresh serum materials, disregarding sign, were 11% for ape A-I and 28% for ape B. When the sign was considered, they yielded a mean value of 2% for ape A-I and 39% for ape B ( Table 2 ). The total slope variation is relatively small for the doseresponse curves for the lyophilized serum materials. The Table 3 ). The percent of total analytical variability attributed to antisera in this study averages around 10%, whereas laboratory error accounted for 40% and 45%, respectively, for ape A-I and B.
5% for ape B (
The bias of the slopes of the dose-response curves for the apo-RM vs the slopes of the fresh sera should indicate degrees of possible nonspecific differences in the lyophilized and fresh sera. When the sign of the slope bias is disregarded, differences in anti-ape A-I sera account for a very small fraction of the overall percent variability. When the sign in considered, antisera contribution appears to affect slopebias more for ape B. While the slope bias with antisera for ape B is a relatively high percentage (39%) of the total variation (Table 2 ), the total contributionof slope variation must be related to the 5% total variation attributed to antisera (Table 3) for concentration measurements of ape B for the apo-RM. The total slope variation in the reported data obviously is a minor contributor to total analytical variation for ape measurements, but it may reflect minor differences between fresh and lyophilized sera for ape B that are not observed for ape A-I. The total variation in concentration for the apo-RM due to antisera was less than 8% (Table 3X The differences in concentration determined within laboratories for both ape A-I and B were generally less than 12%, with a few exceptions for ape B. These differences tended to cluster around zero for both apolipoproteins measured. The IRA gave relatively greater concentration values for three laboratories measuring ape B (Figure 3) . These laboratories We tried to produce a reference type of pelyclonalantiserum for use as the common antiserum (IRA) source in the participating laboratories, to minimize variation in determining consensus values for the apo-RM. Caution must be used when comparing the properties of antiserum to explain their interaction in a particular assay procedure. The rabbit pelyclonal antiserum supplied to each participating laboratory was the result of multiple injections of antigen isolated from different donors and was collected during many months from several animals and pooled. These factors could produce an antiserum product with exceptionally broad specificity and might obscure differences between antisera of more narrow specificity or monoclonal antiserum measuring specific epitopes. Agreement between results achieved with the LA and with the IRA was not achieved in all laboratories. This may represent difficulties of incorporating the antiserum into a particular assay configuration or differences in the performance of the antiserum in a particular laboratory. Differences with IRA or LA were not consistent for any particular immune-method.
In addition, the accuracy in determining the percent variation due to antiserum is limited by the large total CV for the quantifications of ape A-I and B.
The data on the percent contribution by antiserum to the total analytical error suggest that total variation of results for ape A-I and B will probably decrease when more attention is given to methods and to diminishing the nonantiserum sources of analytical error. These findings suggest that criteria for suitable antiserum for immunoassay of ape A-I and B are primarily 
